N

Active Director Director DIN 11748889
DIN 11748889 First appointment May 2026 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since May 2026
Shareholding value Locked Premium profile

About Nishi

Nishi has experience in corporate governance. Holds Director role. Currently with 1 company, including Globinova Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 11748889
Primary Designation Director
First Appointment 30 May 2026
Oldest Company Age Not Provided

Current companies

Company Designation Appointment Founded Status
Globinova Pharma Private Limited U46497KA2026PTC221740
Director 30 May 2026 2026 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Globinova Pharma Private Limited
Premium access

Shareholding and investment profile for Nishi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nishi

Nishi has experience in corporate governance. Holds Director role. Currently with 1 company, including Globinova Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

Nishi is associated with 1 company as Director.

Nishi has expertise in General Business.

Nishi has extensive experience in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available